Klivira
Request demo

Navigating Anthem (Elevance Health) Emgality Prior Authorization

Klivira simplifies the complex process of obtaining Anthem (Elevance Health) Emgality prior authorization for your patients, integrating directly with your EMR and payer systems.

Emgality (galcanezumab) is a critical therapy for migraine prevention and episodic cluster headache, but its status as a specialty medication often necessitates prior authorization (PA). For clinics and health systems managing Anthem (Elevance Health) beneficiaries, understanding the specific PA requirements, submission pathways, and utilization management criteria is crucial for timely patient access and optimized revenue cycles. This guide outlines the operational considerations for Emgality PA with Anthem-licensed plans.

Emgality (Galcanezumab) and Prior Authorization Landscape

Emgality, a calcitonin gene-related peptide (CGRP) inhibitor, is prescribed for the preventive treatment of migraine in adults and for the treatment of episodic cluster headache. As a high-cost specialty medication, Emgality typically requires prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans, including those offered by Anthem (Elevance Health) operating companies. The PA process ensures medical necessity and adherence to formulary guidelines.

Anthem (Elevance Health) Prior Authorization Channels for Emgality

Emgality's prior authorization pathway with Anthem-licensed plans depends on whether it is covered under the medical or pharmacy benefit. For pharmacy benefit Emgality, submissions are routed through CarelonRx, Elevance Health's in-house PBM, and can be initiated via ePA partners like CoverMyMeds and Surescripts. Medical benefit Emgality PA submissions are typically processed through Availity Essentials, Anthem's primary multi-payer provider workspace, or via X12 278 transactions through clearinghouses.

Understanding Anthem's Utilization Management Policies for Emgality

Anthem operating companies publish medical policies and clinical utilization management guidelines that dictate coverage criteria for specialty drugs like Emgality. These policies are accessible through provider sites via Availity, with each state-licensed Anthem plan maintaining its own index. Providers should consult the specific policy number, plan-state context, and effective date to understand requirements such as step therapy, quantity limits, and diagnostic criteria before submission.

Common Denial Reasons and Appeals for Emgality with Anthem

Denials for Emgality prior authorizations from Anthem-licensed plans often stem from medical necessity not being met, failure to complete required step therapy, or insufficient documentation. Non-formulary status or site-of-service mismatches can also lead to denials. When a denial occurs, the appeals process for standard medical PA routes through the Anthem operating-company appeals process, with peer-to-peer reviews available to discuss clinical rationale.

Key Considerations for Emgality PA with Anthem

  • Verify whether Emgality is covered under the medical or pharmacy benefit for the specific patient's Anthem plan.
  • Utilize Availity for medical benefit PA submissions and status checks, or CoverMyMeds/Surescripts for pharmacy benefit ePA.
  • Consult state-specific Anthem medical policies via Availity for current clinical criteria, step therapy, and quantity limits.
  • Ensure comprehensive documentation supporting medical necessity, diagnosis, and previous treatment failures.
  • Understand state-specific turnaround time regulations for commercial plans and CMS-0057-F requirements for Medicare Advantage and Medicaid managed care.
  • Prepare for potential peer-to-peer discussions to address medical necessity denials.

Frequently asked questions

How do I determine if Emgality is covered under the pharmacy or medical benefit for an Anthem patient?

Coverage for specialty drugs like Emgality depends on the specific Anthem plan and its formulary design. You can typically verify benefit coverage and associated prior authorization requirements through the patient's benefit lookup tool on Availity Essentials or by contacting Anthem provider services directly.

What are the primary submission channels for Anthem Emgality prior authorization?

For pharmacy benefit Emgality, submissions are often handled by CarelonRx and can be facilitated through ePA platforms like CoverMyMeds or Surescripts. For medical benefit Emgality, prior authorizations are typically submitted via Availity Essentials or through X12 278 transactions via your clearinghouse.

Where can I find Anthem's clinical criteria for Emgality prior authorization?

Anthem operating companies publish their medical policies and clinical guidelines on their provider websites, accessible via Availity. It is crucial to consult the specific state-licensed Anthem plan's policy, referencing the policy number and effective date, as criteria can vary by state and plan type.

What are common reasons for Emgality prior authorization denials from Anthem?

Common denial reasons for Emgality PA include insufficient documentation of medical necessity, failure to meet step therapy requirements, or not adhering to quantity limits. Denials may also occur if the requested site of service does not align with Anthem's policies or if the drug is non-formulary.

What is the process for appealing an Emgality PA denial from Anthem?

The appeal process for an Emgality PA denial typically follows the standard Anthem operating-company appeals pathway, as outlined in the provider manual. This often includes options for reconsideration, peer-to-peer review with an Anthem medical director, and formal appeals. Ensure all necessary clinical documentation is submitted with your appeal.

Does Anthem (Elevance Health) support electronic prior authorization (ePA) for Emgality?

Yes, Anthem-licensed plans support various forms of electronic prior authorization. For pharmacy benefit Emgality, ePA is available through partners like CoverMyMeds and Surescripts via CarelonRx. For medical benefit PAs, Anthem accepts X12 278 transactions, and Klivira integrates directly with these electronic channels to streamline submissions.

Related coverage

Other emgality prior authorization by payer

Other emgality prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo